✦ LIBER ✦

Combination of azacitidine and ESA in myelodysplastic patients: The need for prospective studies

✍ Scribed by Massimo Breccia; Giuseppina Loglisci; Adriano Salaroli; Alessandra Serrao; Luigi Petrucci; Irene Zacheo; Giuliana Alimena

Book ID: 113773687
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 109 KB
Volume: 36
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2012.02.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and II study of azacitidine in J

Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

✍ Toshiki Uchida; Yoshiaki Ogawa; Yukio Kobayashi; Takayuki Ishikawa; Haruhiko Oha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

Combination of vorinostat and low dose c

Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes

✍ Prebet, Thomas; Braun, Thorsten; Beyne-Rauzy, Odile; Dreyfus, Francois; Stammato 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Azacitidine for treatment of patients wi

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

✍ Katharina Götze; Uwe Platzbecker; Aristoteles Giagounidis; Detlef Haase; Michael 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 175 KB

Azacitidine for the treatment of lower r

Azacitidine for the treatment of lower risk myelodysplastic syndromes : A retrospective study of 74 patients enrolled in an Italian named patient program

✍ Pellegrino Musto; Luca Maurillo; Alessandra Spagnoli; Antonella Gozzini; Flavia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

## Abstract ## BACKGROUND: Azacitidine induces responses and prolongs overall survival compared with conventional care regimens in patients who have high‐risk myelodysplastic syndromes (MDS). However, limited data are available concerning the efficacy and safety of azacitidine in patients who have

Randomized Controlled Trial of Azacitidi

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

✍ Silverman, L. R. 📂 Article 📅 2002 🏛 American Society of Clinical Oncology 🌐 English ⚖ 185 KB

Pilot study on combination of azacitidin

Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast

✍ Joon Ho Moon; Soo Jung Lee; Yoo Jin Lee; Byung Woog Kang; Yee Soo Chae; Jong Gwa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 192 KB